Advanced Malignant Melanoma: Immunologic and Multimodal Therapeutic Strategies

Immunologic treatment strategies are established in malignant melanoma treatment, mainly focusing on Interleukin-2 in advanced disease and interferon alpha in the adjuvant situation. In advanced disease, therapies with IL-2, interferon and different chemotherapeutic agents were not associated with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Halama, Niels, Zoernig, Inka, Jaeger, Dirk
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836142/
https://www.ncbi.nlm.nih.gov/pubmed/20224761
http://dx.doi.org/10.1155/2010/689893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836142/
https://www.ncbi.nlm.nih.gov/pubmed/20224761
http://dx.doi.org/10.1155/2010/689893

Ejemplares similares